CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
- 4 Exercise or conversion Director acquired 12,345 shares (option exercise)
- 4 Exercise or conversion Director acquired 10,288 shares (option exercise)
- 4 Exercise or conversion Director acquired 8,230 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other disposition 10% owner disposed of 2,437,000 shares (other)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion EVP Bus. & Corp. Development acquired 3,086 shares (option exercise)
- 4 Exercise or conversion Director acquired 3,086 shares (option exercise)
- 4 Exercise or conversion CEO acquired 10,288 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 11 of 19 · 370 filings